Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits
NEW YORK / NORTHFIELD, Ill. — December 9, 2025 — Medical‑supply giant Medline Inc. has set the terms for a U.S. initial public offering that could raise up to $5.37 billion and value the company at as much as $55.3 billion, positioning it as the largest U.S. IPO of 2025 and one of the biggest private‑equity‑backed listings on record.Reuters+1 The Illinois‑based manufacturer and distributor of medical‑surgical supplies plans to sell 179 million shares on the Nasdaq under the ticker MDLN at a price range of $26 to $30 per share, with Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan